EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight?

Jarrad M Scarlett, Shannon J Hu, Kimberly M Alonge

Frontiers in Integrative Neuroscience · 25.05.2022 · 16

DOI: 10.3389/fnint.2022.896400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Integrative Neuroscience, online erschienen am 25.05.2022. Verfasst von Jarrad M Scarlett und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington Medicine Diabetes Institute, Seattle, WA, United States. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perineuronal nets (PNNs) are chondroitin-sulfate glycosaminoglycan (CS-GAG) containing extracellular matrix structures that assemble around neurons involved in learning, memory, and cognition. Owing to the unique patterning of negative charges stemming from sulfate modifications to the attached CS-GAGs, these matrices play key roles in mediating glycan-protein binding, signaling interactions, and charged ion buffering of the underlying circuitry. Histochemical loss of PNN matrices has been reported for a range of neurocognitive and neurodegenerative diseases, implying that PNNs might be a key player in the pathogenesis of neurological disorders. In this hypothesis and theory article, we begin by highlighting PNN changes observed in human postmortem brain tissue associated with Alzheimer's disease (AD) and corresponding changes reported in rodent models of AD neuropathology. We then discuss the technical limitations surrounding traditional methods for PNN analyses and propose alternative explanations to these historical findings. Lastly, we embark on a global re-evaluation of the interpretations for PNN changes across brain regions, across species, and in relation to other neurocognitive disorders.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseasechondroitin sulfatesextracellular matrixglycosaminoglycansimmunohistochemistrymass spectrometryperineuronal netsproteoglycans

Autor:innen und Institutionen

  • Department of Medicine, University of Washington Medicine Diabetes Institute, Seattle, WA, United States.
  • Department of Pediatric Gastroenterology and Hepatology, Seattle Children's Hospital, Seattle, WA, United States.

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIA NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Aging
  • U.S. Department of Defense

Zitieren

APA

Scarlett, J. M., Hu, S. J., & Alonge, K. M. (2022). The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight?. Frontiers in Integrative Neuroscience, 16. https://doi.org/10.3389/fnint.2022.896400

Vancouver

Scarlett JM, Hu SJ, Alonge KM. The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight?. Frontiers in Integrative Neuroscience. 2022;16. doi:10.3389/fnint.2022.896400

BibTeX
@article{Scarlett2022,
  author = {Scarlett, Jarrad M and Hu, Shannon J and Alonge, Kimberly M},
  title = {The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight?},
  journal = {Frontiers in Integrative Neuroscience},
  year = {2022},
  volume = {16},
  doi = {10.3389/fnint.2022.896400}
}
Kostenlos starten →